Cyteir Therapeutics Novice Eulerpool

Cyteir Therapeutics Eulerpool News

Cyteir Therapeutics Novice o delnici

Cyteir Therapeutics spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Cyteir Therapeutics novice zbiramo in objavljamo tukaj.

• 7. marec ·

  Yahoo
  Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
• 7. marec ·

  Thefly.com
  Cyteir Therapeutics announces timeline for voluntarily delisting from Nasdaq
• 20. februar ·

  Business Wire
  Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
• 5. januar ·

  Thefly.com
  Cyteir Therapeutics downgraded to Underperform at BofA, coverage terminated
• 1. november ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 20.00% to 3.06
• 12. oktober ·

  Yahoo
  Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile
• 12. oktober ·

  Thefly.com
  Cyteir: Cohort of CYT-0851 in combo for ovarian cancer well tolerated
• 18. september ·

  SeekingAlpha
  Cyteir: Although The Company Is Winding Down, The Lead Asset Had Promise
• 11. julij ·

  Fintel
  Fmr Now Owns 2.33% of Cyteir Therapeutics (CYT)
• 6. julij ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 7.14% to 2.55